Price
CHART BY
Frequently asked questions
What is Paion's market capitalization?
The market capitalization of Paion is $150.14K. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Paion?
Paion's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.901. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Paion's stock?
Currently, 1 analysts cover Paion's stock, with a consensus target price of $10.86. Analyst ratings provide insights into the stock's expected performance.
What is Paion's revenue over the trailing twelve months?
Over the trailing twelve months, Paion reported a revenue of $15.43M.
What is the EBITDA for Paion?
Paion's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$14.27M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Paion?
Paion has a free cash flow of -$13.42M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Paion have, and what sector and industry does it belong to?
Paion employs approximately 70 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Paion's shares?
The free float of Paion is 6.61M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $150.14K
- EPS (TTM)
- -$2.901
- Free Float
- 6.61M
- Revenue (TTM)
- $15.43M
- EBITDA (TTM)
- -$14.27M
- Free Cashflow (TTM)
- -$13.42M
Pricing
- 52W span
- $0.0004175$0.184
Analyst Ratings
The price target is $10.86 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
PAION AG operates as a pharmaceutical company, which engages in the development of drugs to be used in out-patient and hospital-based sedation, anesthesia, and critical care services. The company also provides management and other services. It focuses on development of the group strategy, administrative tasks, including accounting, legal, human resources, public relations, and controlling. The company was founded by Wolfgang Sohngen and Mariola Söhngen in 2000 and is headquartered in Aachen, Germany.
- Employees
- 70
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- DE000A3E5EG5
- Primary Ticker
- PA8